The differences in the prevalence of cardiovascular disease, its risk factors, and achievement of therapeutic goals among urban and rural primary care patients in …
K Studziński, T Tomasik, A Windak, M Banach… - Journal of Clinical …, 2021 - mdpi.com
A nationwide cross-sectional study, LIPIDOGRAM2015, was carried out in Poland in the
years 2015 and 2016. A total of 438 primary care physicians enrolled 13,724 adult patients …
years 2015 and 2016. A total of 438 primary care physicians enrolled 13,724 adult patients …
[HTML][HTML] The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study
JJ Jóźwiak, K Studziński, T Tomasik, A Windak… - Atherosclerosis …, 2020 - Elsevier
Background and aim To estimate the prevalence of cardiovascular (CV) disease and CV risk
factors among Polish patients. Methods A nationwide cross-sectional study …
factors among Polish patients. Methods A nationwide cross-sectional study …
Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey
T Zdrojewski, B Solnica, B Cybulska… - Kardiologia Polska …, 2016 - journals.viamedica.pl
Background: Poland represents a country of high cardiovascular (CV) risk. The association
between lipid abnormalities and increased CV risk is well established. Therefore, it is …
between lipid abnormalities and increased CV risk is well established. Therefore, it is …
Determinants of Lipid Parameters in Patients without Diagnosed Cardiovascular Disease—Results of the Polish Arm of the EUROASPIRE V Survey
J Ratajczak, A Kubica, P Michalski… - Journal of Clinical …, 2023 - mdpi.com
To assess the determinants of lipid parameters in primary care patients without diagnosed
cardiovascular disease (CVD), a cross-sectional study was conducted during 2018–2019 …
cardiovascular disease (CVD), a cross-sectional study was conducted during 2018–2019 …
[HTML][HTML] Prevalence of cardiovascular risk factors and cardiovascular prevention quality in primary healthcare in Russia and European countries: EURIKA Study …
SA Boytsov - Cardiovascular Therapy and Prevention, 2012 - cardiovascular.elpub.ru
Background. In the Russian Federation (RF), the prevalence of cardiovascular disease
(CVD) and CVD mortality levels are very high. Selected aspects of cardiovascular risk factor …
(CVD) and CVD mortality levels are very high. Selected aspects of cardiovascular risk factor …
[HTML][HTML] Lipid-lowering therapy use in primary and secondary care in Central and Eastern Europe: DA VINCI observational study
M Vrablik, B Seifert, A Parkhomenko, M Banach… - Atherosclerosis, 2021 - Elsevier
Background and aims Central and Eastern Europe (CEE) is a largely understudied region,
despite having the highest cardiovascular disease mortality in Europe. This analysis aimed …
despite having the highest cardiovascular disease mortality in Europe. This analysis aimed …
Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study
T Tomasik, J Jozwiak, A Windak… - European Journal of …, 2011 - academic.oup.com
Abstract Aims To determine:(1) achievement of cholesterol therapy goals in patients
receiving lipid-lowering drugs in Polish primary care between the years 2004 and 2006;(2) …
receiving lipid-lowering drugs in Polish primary care between the years 2004 and 2006;(2) …
Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go
M Firmann, P Marques-Vidal, F Paccaud… - European Journal of …, 2010 - academic.oup.com
Background There is little information regarding the prevalence and management of
dyslipidaemia in Switzerland. Design Cross-sectional population-based study of 3238 …
dyslipidaemia in Switzerland. Design Cross-sectional population-based study of 3238 …
Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study
A Pająk, K Szafraniec, M Polak… - Polskie Archiwum …, 2017 - publicum.umed.lodz.pl
INTRODUCTION Lowering exposure to dyslipidemias is one of the biggest challenges in
cardiovascular disease prevention. OBJECTIVES The aim of the study was to describe the …
cardiovascular disease prevention. OBJECTIVES The aim of the study was to describe the …
[HTML][HTML] Twenty-first century epidemiology of dyslipidemia in Greece: EMENO national epidemiological study
Background Greece was recently reclassified from low-to medium-risk country in terms of
cardiovascular disease, with 27% of cardiovascular deaths attributed to …
cardiovascular disease, with 27% of cardiovascular deaths attributed to …